AstraZeneca

Thumbnail for AstraZeneca’s Imfinzi recommended for EU approval in lung cancer

6 February 2025

AstraZeneca’s Imfinzi recommended for EU approval in lung cancer

Thumbnail for AstraZeneca receives positive NICE recommendations for lung cancer treatments

27 January 2025

AstraZeneca receives positive NICE recommendations for lung cancer treatments

Thumbnail for AstraZeneca invests US$570M in Canada, creating 700 jobs

24 January 2025

AstraZeneca invests US$570M in Canada, creating 700 jobs

Thumbnail for Calquence receives full FDA approval for first-line treatment of Mantle Cell Lymphoma

23 January 2025

Calquence receives full FDA approval for first-line treatment of Mantle Cell Lymphoma

Thumbnail for AstraZeneca elevates South Africa’s role in global health research

11 November 2024

AstraZeneca elevates South Africa’s role in global health research

Thumbnail for AstraZeneca’s Tagrisso gains FDA nod for stage III lung cancer

30 September 2024

AstraZeneca’s Tagrisso gains FDA nod for stage III lung cancer

Thumbnail for FluMist gets FDA approval for self-administration

24 September 2024

FluMist gets FDA approval for self-administration

Thumbnail for Egypt’s Healthcare Authority partners with AstraZeneca Egypt to transform healthcare with digital innovation

13 August 2024

Egypt’s Healthcare Authority partners with AstraZeneca Egypt to transform healthcare with digital innovation

Thumbnail for AstraZeneca completes acquisition of Amolyt Pharma

17 July 2024

AstraZeneca completes acquisition of Amolyt Pharma

Thumbnail for AstraZeneca to invest US$30M in Chennai expansion

8 July 2024

AstraZeneca to invest US$30M in Chennai expansion